Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
Company announcement No. 45 / 2026 Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) Copenhagen, Denmark, September 2, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”)…
Colo. Exits Pharma Group's Challenge Of Drug Discount Law
A Colorado federal court has thrown out a pharmaceutical industry trade group's challenge of a state law requiring drug manufacturers to sell discounted drugs through contracted pharmacies, finding the group failed... To view the full article…
Amid increased tariffs, Sun Pharma to invest, set up plant in US, signs deal
India's largest drugmaker Sun Pharmaceutical Industries has reportedly signed an agreement with the US government to extend affordable medicines to American patients. According to a report by news agency PTI, the Mumbai-based pharma company entered…
Your Nonalcoholic Beer May Actually Have Some Alcohol in It
In the fast-growing nonalcoholic beer business, “zero” doesn't always mean “none.” The proliferation of sober-friendly brews—many of which still contain trace amounts of alcohol—has industry officials and…
Medochemie, Theramir partner to speed up new era of biotech, pharma manufacturing for region
Medochemie Ltd, a leading pharmaceutical company based in Cyprus with a strong international presence, and Theramir Ltd, a biotechnology company specialising in next-generation therapies based on extracellular vesicles and mRNA, have announced a…
BridgeBio Pharma (NASDAQ:BBIO) Earns Buy Rating from HC Wainwright
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report)'s stock had its 'buy' rating restated by equities researchers at HC Wainwright in a research note issued to investors on Wednesday, Benzinga reports. They presently have a $120.00 target price on the…
Public Employees Retirement System of Ohio Makes New $7.84 Million Investment in Royalty Pharma PLC $RPRX
Public Employees Retirement System of Ohio purchased a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The…
Alyeska Investment Group L.P. Purchases New Shares in Nuvectis Pharma, Inc. $NVCT
Alyeska Investment Group L.P. acquired a new stake in shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 275,000 shares of the…
Can a Blood Test Predict Your Risk of Alzheimer's Disease?
Going to the doctor to have tests done has become part of our everyday lives. Often, these checks are done because of symptoms you have experienced, and the doctor is looking to rule in or rule out the possibility that particular causes are behind…
Indian Stock Markets Plunge Amid West Asia Conflict, Rising Crude Oil Prices
Indian stock markets, including the Sensex and Nifty, witnessed a sharp decline in early trading as escalating geopolitical tensions in West Asia and a significant surge in crude oil prices fuelled investor anxiety across global equities. Indian…
Stock markets tumble in early trade on escalating tensions in West Asia, higher oil prices
Stock market benchmark indices Sensex and Nifty slumped in early trade on Wednesday (September 2, 2026), tracking a bearish trend in global equities and higher oil prices due to escalating conflict in West Asia. The 30-share BSE Sensex tanked…
IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications
Louvain-la-Neuve, Belgium, 2 September 2026, 7 a.m. – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its participation in PFAROS, a new European research and innovation…
Incyte Corporation: Why Jakafi Is No Longer The Real Story Here (NASDAQ:INCY)
Incyte Corporation is transitioning from a Jakafi-centric model to a diversified, multi-franchise biotech with several late-stage pipeline assets. 2Q26 results showed 17% underlying net sales growth, broad-based portfolio expansion, and strong…
Deep state bureaucrats are sabotaging Trump's chance for a China megadeal
While headlines are dominated by election news and the war in Iran, our government is quietly getting ready for one of the most important events of the year. In under four weeks, President Donald Trump will host Chinese President Xi Jinping at the…
Nicox Announces Extension of Cash Runway
Press Release Nicox Announces Extension of Cash Runway Cash position, of €8.4 million as of 31 August 2026, sufficient to fund existing operations beyond Q1 2028 NCX 470 U.S. NDA approval milestone would fund operations into 2029, while…
Receive a Daily briefing on Pharma Industry News
Get Started